The Journal of Organic Chemistry
Article
chromatography (60:40 EtOAc/hex, Rf = 0.50) to yield 13h as an
orange amorphous solid (101 mg, 68%). 1H NMR (300 MHz, CDCl3)
δ 7.93 (dd, J = 7.2, 1.6 Hz, 2H), 7.70 (m, 1H), 7.60 (dd, J = 8.2, 6.6
Hz, 2H), 7.32 (m, 5H), 6.37 (dd, J = 16.0, 1.2 Hz, 1H), 6.07 (dd, J =
15.8, 6.4 Hz, 1H), 4.94 (dt, J = 6.6, 1.6 Hz, 1H), 4.66 (m, 1H), 3.35
(td, J = 6.4, 2.0 Hz, 1H), 2.68 (dt, J = 17.2, 7.0 Hz, 1H), 2.40 (dt, J =
17.2, 7.1 Hz, 1H), 2.09 (dt, J = 14.4, 7.2 Hz, 1H), 1.99 (dt, J = 14.4,
7.2 Hz, 1H), 1.33 (d, J = 6.8 Hz, 3H), 1.18 (d, J = 6.9 Hz, 3H); 13C
NMR (75 MHz, CDCl3) δ 169.7, 137.6, 135.4, 134.2, 132.0, 129.8,
129.6, 128.8, 128.6, 128.4, 126.5, 63.5, 51.8, 47.3, 29.1, 20.7, 20.2,
18.78; IR (thin film) 3059, 2975, 1639, 1446, 1305, 1145 cm−1; HRMS
(ESI-TOF) m/z [M + Na]+ calcd for C22H25NO3SNa 406.1453, found
406.1447.
trans-6-(4-Methoxyphenyl)-5-(phenylsulfonyl)-1-propylpiperidin-
2-one (13i). General procedure B. The residue was purified by flash
column chromatography (60:40 EtOAc/hex, Rf = 0.42) to yield 13i as
a foam (96 mg, 69%). 1H NMR (600 MHz, CDCl3) δ 7.92 (d, J = 8.4
Hz, 2H), 7.69 (t, J = 7.4 Hz, 1H), 7.60 (t, J = 7.8 Hz, 2H), 6.97 (d, J =
8.6 Hz, 2H), 6.84 (m, 2H), 5.18 (m, 1H), 3.93 (m, 1H), 3.77 (s, 3H),
3.30 (m, 1H), 2.81 (m, 1H), 2.45 (m, 2H), 2.01 (m, 2H), 1.61 (m,
2H), 0.88 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 169.2,
159.5, 134.2, 131.5, 129.5, 128.6, 127.3, 114.5, 105.0, 64.9, 57.5, 55.3,
48.0, 28.1, 20.3, 17.6, 11.3; IR (thin film) 2964, 2920, 1633, 1250,
1144 cm−1; HRMS (ESI-TOF) m/z [M + Na]+ calcd for
C21H25NO4SNa 410.1402, found 410.1400.
trans-6-(4-Chlorophenyl)-5-(phenylsulfonyl)-1-propylpiperidin-2-
one (13j). General procedure C. The residue was purified by flash
column chromatography (60:40 EtOAc/hex, Rf = 0.40) to yield 13j as
a foam (133 mg, 87%). 1H NMR (600 MHz, CDCl3) δ 7.89 (m, 2H),
7.69 (m, 1H), 7.59 (m, 2H), 7.28 (m, 2H), 7.01 (m, 2H), 5.21 (s, 1H),
3.92 (ddd, J = 13.6, 9.0, 7.4 Hz, 1H), 3.27 (td, J = 5.1, 2.2 Hz, 1H),
2.78 (ddd, J = 17.4, 10.1, 6.8 Hz, 1H), 2.41 (m, 2H), 1.96 (m, 2H),
1.59 (m, 2H), 0.86 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3)
δ 169.2, 138.3, 137.2, 134.4, 134.2, 129.6, 129.4, 128.5, 127.5, 64.6,
57.5, 48.0, 28.1, 20.3, 17.9, 11.3; IR (thin film) 2964, 2937, 1641, 1306,
1146 cm−1; HRMS (ESI-TOF) m/z [M + Na]+ calcd for
C20H22ClNO3SNa 414.0907, found 414.0921.
2.43 (dt, J = 17.5, 6.6 Hz, 1H), 2.09 (m, 2H), 1.58 (m, 1H), 1.49 (m,
1H), 0.85 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 169.4,
151.3, 143.0, 137.3, 134.2, 129.5, 128.5, 110.6, 108.4, 61.8, 52.9, 47.8,
28.5, 20.4, 19.0, 11.3; IR (thin film) 2965, 2933, 2875, 1647, 1503,
1306, 1148 cm−1; HRMS (ESI-TOF) m/z [M + Na]+ calcd for
C18H21NO4SNa 370.1089, found 370.1076.
rel-(4R,5S,6R)-1,4-Dimethyl-6-phenyl-5-(phenylsulfonyl)piperidin-
2-one (14). General procedure C with anhydride 3c. The residue was
purified by flash column chromatography (70:30 EtOAc/hex, Rf1 =
0.35) to yield 14 as a solid (111 mg, 87%). Mp 127.4−128.1 °C; H
NMR (600 MHz, CDCl3) δ 7.99 (m, 2H), 7.74 (m, 1H), 7.65 (m,
2H), 7.35 (dd, J = 8.4, 7.1 Hz, 2H), 7.28 (m, 1H), 7.05 (d, J = 6.8 Hz,
2H), 5.21 (s, 1H), 3.45 (d, J = 6.9 Hz, 1H), 2.91 (s, 3H), 2.53 (m,
1H), 2.45 (dd, J = 15.7, 5.3 Hz, 1H), 2.11 (dd, J = 15.8, 11.6 Hz, 1H),
0.91 (d, J = 6.7 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 171.1, 139.3,
137.0, 134.5, 129.6, 129.4, 129.1, 127.9, 125.3, 73.7, 60.3, 38.1, 34.4,
29.1, 22.4; IR (thin film) 2912, 1658, 1305, 1130 cm−1; HRMS (ESI-
TOF) m/z [M + Na]+ calcd for C19H21NO3SNa 366.1140, found
366.1145.
rel-(3S,5R,6S)-1,3-Dimethyl-5-(phenylsulfonyl)-6-(2,4,6-
trimethoxyphenyl)piperidin-2-one (15). General procedure C with
anhydride 3d. The residue was purified by flash column chromatog-
raphy (80:20 EtOAc/hex, Rf = 0.35) to yield 15 as a white solid (169
1
mg, 79%). Mp 143.7−144.3 °C; H NMR (600 MHz, CDCl3) δ 7.70
(d, J = 7.5 Hz, 2H), 7.50 (t, J = 7.4 Hz, 1H), 7.37 (t, J = 7.7 Hz, 2H),
5.89 (s, 2H), 5.31 (d, J = 9.5 Hz, 1H), 4.22 (ddd, J = 13.4, 9.5, 3.6 Hz,
1H), 3.72 (s, 3H), 3.71 (s, 6H), 2.48 (m, 4H, NCH3 and 1 methylene
H), 2.40 (m, 1H), 1.84 (m, 1H), 1.27 (d, J = 6.9 Hz, 3H); 13C NMR
(150 MHz, CDCl3) δ 173.1, 161.4, 158.6, 137.4, 133.4, 128.50, 128.48,
106.8, 90.6, 61.9, 55.6, 55.2, 51.9, 35.0, 31.8, 29.3, 17.1; IR (thin film)
3006, 2939, 1614, 1286, 1134 cm−1; HRMS (ESI-TOF) m/z [M +
H]+ calcd for C22H28NO6S 434.1637, found 434.1649.
Methyl trans-1-Allyl-5-oxo-3-(phenylsulfonyl)-2-((E)-styryl)-
pyrrolidine-3-carboxylate (17). Allylamine (0.29 mL, 3.8 mmol)
and trans-cinammaldehyde (0.53 mL, 4.2 mmol) were added to a
round-bottom flask containing THF (38 mL) and Na2SO4 (3.3 g, 23.0
mmol), and the mixture was allowed to stir for 1 h. The anhydride
(0.92 g, 3.8 mmol) was added, and the resulting mixture was allowed
to stir for 2 h. The Na2SO4 was filtered off, and the solvent was
evaporated in vacuo. The residue was redissolved in EtOAc and
washed with 10% HCl and brine. The organic layer was dried over
Na2SO4 and evaporated to dryness. The residue was triturated with
hexanes, transferred to a fritted funnel, and washed in portions with
hexanes five times (5 mL) and two times with a 9:1 mixture of cold
hexanes and CHCl3 (10 mL total), yielding 1.2 g of an off-white solid,
which was ∼85% pure by NMR. A portion of the resulting acid (0.885
g, 2.2 mmol) was redissolved in anhydrous toluene and methanol (60
mL:30 mL), and TMSCHN2 (2.2 mL, 4.4 mmol, 2 M in hexanes) was
added at 0 °C dropwise over a period of 5 min. The mixture was
allowed to stir for 1.5 h and monitored by TLC for disappearance of
the starting material. The solvent was removed in vacuo, and the crude
mixture was purified by flash column chromatography (EtOAc/hex
30−60%), yielding 17 (0.85 g, 92%) as an amorphous solid (50:50
EtOAc/hex, Rf = 0.44). 1H NMR (600 MHz, CDCl3) δ 7.98−7.89 (m,
2H), 7.81−7.56 (m, 3H), 7.41−7.24 (m, 5H), 6.54 (d, J = 15.8 Hz,
1H), 5.84−5.72 (m, 2H), 5.34−5.25 (m, 2H), 5.02 (d, J = 8.4 Hz,
1H), 4.40 (ddt, J = 15.3, 4.7, 1.7 Hz, 1H), 3.71−3.42 (m, 3H), 3.44−
3.27 (m, 2H), 3.13 (d, J = 18.2 (gem) Hz, 1H); 13C NMR (150 MHz,
CDCl3) δ 169.4, 165.3, 136.7, 135.8, 135.2, 135.0, 131.7, 130.6, 129.3,
128.9, 128.9, 126.8, 121.9, 119.4, 76.1, 62.0, 53.4, 43.8, 35.6. IR (thin
film) 1736, 1715, 1694 (CO), 1309, 1148 (SO) cm−1; HRMS
(ESI-TOF) m/z [M + Na]+ calcd for C23H23NO5SNa 448.1195, found
448.1195.
trans-6-(2-Ethylphenyl)-5-(phenylsulfonyl)-1-propylpiperidin-2-
one (13k). General procedure C. The residue was purified by flash
column chromatography (60:40 EtOAc/hex, Rf = 0.42) to yield 13k as
1
a foam (92 g, 61%). H NMR (600 MHz, CDCl3) δ 7.95 (d, J = 8.4
Hz, 2H), 7.70 (t, J = 7.4 Hz, 1H), 7.61 (t, J = 7.9 Hz, 2H), 7.24 (m,
1H), 7.17 (m, 2H), 7.05 (d, J = 7.8 Hz, 1H), 5.51 (s, 1H), 3.97 (m,
1H), 3.14 (m, 1H), 2.94 (m, 1H), 2.53 (dd, J = 18.3 (gem), 7.4 Hz,
1H), 2.42 (m, 1H), 2.34 (m, 2H), 2.07 (m, 1H), 1.98 (m, 1H), 1.69
(m, 2H), 1.14 (t, J = 7.5 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H); 13C NMR
(151 MHz, CDCl3) δ 168.9, 141.1, 137.6, 136.1, 134.3, 129.63, 129.60,
128.63, 128.60, 126.5, 126.1, 62.5, 54.2, 48.2, 27.3, 24.3, 20.4, 16.3,
15.4, 11.5; IR (thin film) 3006, 2966, 1639, 1300, 1144 cm−1; HRMS
(ESI-TOF) m/z [M + Na]+ calcd for C22H27NO3SNa 408.1609, found
408.1620.
trans-6-(3,5-Dimethoxyphenyl)-5-(phenylsulfonyl)-1-propylpiper-
idin-2-one (13l). General procedure B. The residue was purified by
flash column chromatography (80:20 EtOAc/hex, Rf = 0.50) to yield
13l as a foam (104 mg, 64%). 1H NMR (600 MHz, CDCl3) δ 7.92 (m,
2H), 7.69 (t, J = 7.1 Hz, 1H), 7.60 (m, 2H), 6.32 (s, 1H), 6.16 (d, J =
2.1 Hz, 2H), 5.14 (d, J = 2.1 Hz, 1H), 3.95 (ddd, J = 13.4, 9.6, 6.5 Hz,
1H), 3.72 (s, 6H), 3.34 (td, J = 4.8, 1.9 Hz, 1H), 2.79 (m, 1H), 2.46
(m, 2H), 2.03 (m, 2H), 1.63 (m, 2H), 0.89 (t, J = 7.4 Hz, 3H); 13C
NMR (150 MHz, CDCl3) δ 169.1, 161.5, 142.3, 137.4, 134.2, 129.6,
128.6, 104.2, 99.5, 64.6, 58.0, 55.4, 48.2, 28.0, 20.3, 17.7, 11.3; IR (thin
film) 2962, 2937, 1641, 1594, 1306, 1145 cm−1; HRMS (ESI-TOF)
m/z [M + Na]+ calcd for C22H27NO5SNa 440.1508, found 440.1517.
trans-6-(Furan-2-yl)-5-(phenylsulfonyl)-1-propylpiperidin-2-one
(13m). General procedure B. The residue was purified by flash column
chromatography (70:30 EtOAc/hex, Rf = 0.35) to yield 13m as a foam
Methyl trans-3-Oxo-1-(phenylsulfonyl)-2,3,5,7a-tetrahydro-
1H-pyrrolizine-1-carboxylate (18). Ester 17 (0.602 g, 1.41 mmol)
was dissolved in anhydrous benzene (114 mL), which was degassed by
bubbling with argon for approximately 5 min. Then Grubbs second-
generation catalyst (35 mg, 3 mol %) was added, and the mixture was
heated to reflux for 9 h. The solvent was evaporated in vacuo, and the
residue was redissolved in EtOAc (30 mL). Saturated NH4Cl (10 mL)
1
(101 mg, 75%). H NMR (600 MHz, CDCl3) δ 7.88 (d, J = 7.2 Hz,
2H), 7.65 (m, 1H), 7.56 (t, J = 7.7 Hz, 2H), 7.27 (dd, J = 1.9, 1.0 Hz,
1H), 6.24 (m, 1H), 6.10 (m, 1H), 5.16 (d, J = 2.9 Hz, 1H), 3.78 (ddd,
J = 13.6, 9.6, 6.4 Hz, 1H), 3.59 (td, J = 6.1, 3.1 Hz, 1H), 2.71 (m, 2H),
2608
dx.doi.org/10.1021/jo500050n | J. Org. Chem. 2014, 79, 2601−2610